A detailed history of Frank, Rimerman Advisors LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Frank, Rimerman Advisors LLC holds 6,795 shares of EW stock, worth $444,936. This represents 0.04% of its overall portfolio holdings.

Number of Shares
6,795
Previous 21 32257.14%
Holding current value
$444,936
Previous $2,000 31250.0%
% of portfolio
0.04%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$84.3 - $94.31 $571,048 - $638,855
6,774 Added 32257.14%
6,795 $627,000
Q4 2023

Feb 13, 2024

BUY
$61.71 - $77.76 $1,295 - $1,632
21 New
21 $1.6 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Frank, Rimerman Advisors LLC Portfolio

Follow Frank, Rimerman Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frank, Rimerman Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frank, Rimerman Advisors LLC with notifications on news.